TP53 and familial pancreatic carcinoma: The KPflC mouse model, in which pancreatic cancer cells have lost p53 expression, has lower fibrosis (28) and rates of metastasis (37) compared to the KPC mouse model, which harbors a gain-of-function R172H mutation in p53.